...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and Antitumor Activity of 1,5,6-Substituted E-3-(2-Chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones(1).
【24h】

Synthesis and Antitumor Activity of 1,5,6-Substituted E-3-(2-Chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones(1).

机译:1,5,6-取代的E-3-(2-氯-3-吲哚基亚甲基)-1,3-二氢吲哚-2-酮的合成及其抗肿瘤活性(1)。

获取原文
获取原文并翻译 | 示例
           

摘要

Synthesis and antitumor activity of new E-3-(2-chloro-3-indolylmethylene)-1,3-dihydroindol-2-ones are described. All compounds prepared were active in the primary test (three human cell lines) and entered the second level (60 human cell lines). The most active antitumor derivatives bear the same substituents in the chloroindole ring and are not CDK1 inhibitors. A COMPARE analysis showed that they could act as tubulin binders. In most cell lines, E-3-(2-chloro-5-methoxy-6-methyl-3-indolylmethylene)-1,3-dihydroindol-2-on e was a growth inhibitor more potent than vincristine.
机译:描述了新的E-3-(2-氯-3-吲哚基亚甲基)-1,3-二氢吲哚-2-酮的合成和抗肿瘤活性。制备的所有化合物均在主要测试(三种人类细胞系)中具有活性,并进入第二级(60种人类细胞系)。活性最高的抗肿瘤衍生物在氯吲哚环上具有相同的取代基,而不是CDK1抑制剂。比较分析表明它们可以充当微管蛋白结合剂。在大多数细胞系中,E-3-(2-氯-5-甲氧基-6-甲基-3-吲哚基亚甲基)-1,3-二氢吲哚-2-酮是比长春新碱更有效的生长抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号